Stocks and Investing Stocks and Investing
Thu, December 2, 2021
Wed, December 1, 2021
Tue, November 30, 2021
Mon, November 29, 2021

Elemer Piros Downgraded (APLS) to Hold and Decreased Target to $40 on, Nov 29th, 2021


Published on 2024-10-27 18:48:02 - WOPRAI, Elemer Piros
  Print publication without navigation


Elemer Piros of Roth Capital, Downgraded "Apellis Pharmaceuticals, Inc." (APLS) to Hold and Decreased Target from $46 to $40 on, Nov 29th, 2021.

Elemer has made no other calls on APLS in the last 4 months.



There are 7 other peers that have a rating on APLS. Out of the 7 peers that are also analyzing APLS, 2 agree with Elemer's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $38 on, Friday, September 10th, 2021
  • Laura Chico of "Wedbush" Downgraded from Buy to Hold and Decreased Target to $39 on, Friday, September 10th, 2021


These are the ratings of the 5 analyists that currently disagree with Elemer


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $72 on, Wednesday, November 24th, 2021
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $116 on, Tuesday, November 9th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $70 on, Friday, September 10th, 2021
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $69 on, Friday, September 10th, 2021
  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $74 on, Thursday, August 19th, 2021